328449: BD SafetyGlide 3/10ml Insulin Syringe 31G x 15/64"

Sign in to add this product to your favorites!
| Price: | $39.00 per box of 100 |
|---|---|
| Quantity: | |
| In Stock: | 3 box of 100 |
| Expiration: | 02-2028 (or later) |
| Express: | Need it tomorrow? Order in next 6 hours 39 minutes and choose overnight shipping at checkout. |
Additional Details
BD SafetyGlide™ Insulin Syringe
The BD SafetyGlide™ 6mm insulin syringe is a safety-engineered insulin syringe that helps protect healthcare professionals and other caregivers from accidental needlestick and other sharps injuries. It features a sliding safety arm that can be activated with one hand.
AccessGUDID Info
- FDA Product Code: MEG
- FDA Product Code Name: SYRINGE, ANTISTICK
- GMDN Term Code: 38501
- GMDN Term Name: Insulin syringe/needle, basic
- GMDN Term Description: A sterile device consisting of a calibrated barrel (cylinder) with plunger intended to be used to administer an injection of insulin to a patient subcutaneously; a non-retractable needle is included, either attached or detached (usually capped for user protection). The syringe is typically made of plastic and silicone materials and will have plunger anti-sticking properties allowing smooth plunger movement. It can be used by healthcare personnel or patient, and will allow for the aspiration of the pharmaceutical from its container for direct administration to the patient or via an intravenous (IV) port, heparin lock, or saline lock. This is a single-use device.
Manufacturer
Becton, Dickinson and Company (BD) is a global medical technology leader providing a broad range of products across medication management, diagnostics, and surgical care. BD’s Medical segment includes industry-leading solutions in medication delivery, such as BD syringes, needles, and infusion systems, as well as devices for diabetes care and pharmaceutical pre-fillable systems. The Life Sciences division supports clinical diagnostics and research with products like BD Vacutainer blood collection systems and BD Veritor rapid testing platforms. BD’s Interventional segment includes advanced surgical products from acquired brands like Bard and Tepha, with specialties in infection prevention, hernia repair, biosurgery, and urology. With a focus on advancing health through technology, BD supports hospitals, labs, and clinicians worldwide in improving safety, efficiency, and patient outcomes.
IN-DATE